Arsenal Capital Partners ("Arsenal"), a leading private equity firm that invests in middle-market healthcare and specialty industrials companies, announced today the acquisition of Accumen Inc. ("Accumen"), a leading technology-enabled provider of health system performance optimization solutions, from Accretive, LLC, a specialized investment firm based in New York.  The terms of the acquisition were not disclosed.

Founded in 2011, Accumen provides end-to-end strategy and services to drive value and long-term sustainability for healthcare providers’ clinical laboratories, outreach services, patient blood management systems, and imaging services.

Steve McLean, a Senior Partner of Arsenal said, "Accumen has a best-in-class management team with highly valuable expertise in providing operating and clinical improvements for its hospital and health system clients.  Accumen serves the critical market need for the optimization of in-house ancillary services to support the healthcare industry’s broader value-based care goals and initiatives.”

Jeff Osborne, the CEO of Accumen, said, "We are proud of the business that we have built and are excited to partner with Arsenal.  We chose Arsenal because of its deep healthcare and technology-enabled business services expertise and are confident that Arsenal can provide experience and resources to support the company’s growth strategy."

BG Porter, an Industry & Operations Partner of Arsenal and recently named Chair of Accumen’s board, added, "Arsenal and its portfolio companies are committed to improving the quality and cost effectiveness of healthcare providers.  We are excited to work with Jeff and his team to expand Accumen’s innovative, technology-enabled solutions and support the company through its next phase of growth.”

MTS Health Partners, L.P. acted as a financial advisor, and Ropes & Gray LLP acted as a legal advisor to Arsenal.  Nexus Health Capital acted as a financial advisor, and Greenberg Traurig, P.A. acted as a legal advisor to Accumen.